- Home
- TCBP vs LIPO Comparison
TCBP vs LIPO Comparison
Compare TCBP & LIPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCBP
- LIPO
- Stock Information
- Founded
- TCBP 2013
- LIPO 2005
- Country
- TCBP United Kingdom
- LIPO United States
- Employees
- TCBP N/A
- LIPO N/A
- Industry
- TCBP Biotechnology: Biological Products (No Diagnostic Substances)
- LIPO Biotechnology: Pharmaceutical Preparations
- Sector
- TCBP Health Care
- LIPO Health Care
- Exchange
- TCBP Nasdaq
- LIPO Nasdaq
- Market Cap
- TCBP 3.0M
- LIPO 3.5M
- IPO Year
- TCBP 2022
- LIPO 2022
- Fundamental
- Price
- TCBP $0.65
- LIPO $2.66
- Analyst Decision
- TCBP Strong Buy
- LIPO Strong Buy
- Analyst Count
- TCBP 1
- LIPO 1
- Target Price
- TCBP $3.00
- LIPO $16.00
- AVG Volume (30 Days)
- TCBP 814.6K
- LIPO 169.2K
- Earning Date
- TCBP 02-09-2025
- LIPO 11-14-2024
- Dividend Yield
- TCBP N/A
- LIPO N/A
- EPS Growth
- TCBP N/A
- LIPO N/A
- EPS
- TCBP N/A
- LIPO N/A
- Revenue
- TCBP N/A
- LIPO $483,533.00
- Revenue This Year
- TCBP N/A
- LIPO N/A
- Revenue Next Year
- TCBP N/A
- LIPO N/A
- P/E Ratio
- TCBP N/A
- LIPO N/A
- Revenue Growth
- TCBP N/A
- LIPO 0.78
- 52 Week Low
- TCBP $0.44
- LIPO $2.21
- 52 Week High
- TCBP $41.50
- LIPO $12.00
- Technical
- Relative Strength Index (RSI)
- TCBP 36.84
- LIPO 45.43
- Support Level
- TCBP $0.45
- LIPO $2.53
- Resistance Level
- TCBP $0.70
- LIPO $2.79
- Average True Range (ATR)
- TCBP 0.08
- LIPO 0.29
- MACD
- TCBP 0.10
- LIPO -0.01
- Stochastic Oscillator
- TCBP 55.58
- LIPO 12.62
About TCBP TC BioPharm (Holdings) plc
TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform. Harnessing the innate ability of GD-Ts has enabled the company to develop a range of clinical-stage cell therapies designed to combat cancer and viral infection.
About LIPO Lipella Pharmaceuticals Inc.
Lipella Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. The company's product candidates include LP-10, LP-310 and LP-410 which can be helpful in treatment of Hemorrahagic Cystitis, Oral Licen Planus and Oral Graft.